The relatively small overlap between mouse and human HIF-2α-dependent genes may be due to inherent differences between mice and humans, to the very different experimental settings of acute pharmacological inhibition versus tumour evolution in the genetic absence of Hif2a, or to specific features of this particular model of ccRCC. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.